Skip to main content

OUP Management Co., LLC

SEC CIK
0001880124
Latest filing
Nov 9, 2023

Holdings in Q3 2023

Holdings as of Sep 30, 2023, filed Nov 9, 2023. Long positions only; changes compare share counts with Q2 2023.

Institution overview
Positions
12
0 vs. Q2 2023
Portfolio value
$44.5M
−$14.2M (−24.2%) vs. Q2 2023
Filed
Nov 9, 2023
SEC
Holdings of OUP Management Co., LLC in Q3 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS2,937,615$19.0M42.7%00.0%UnchangedHistory
JBIOJade Biosciences, Inc.COM603,762$8.19M18.4%00.0%UnchangedHistory
CYTCyteir Therapeutics, Inc.COM2,459,572$6.99M15.7%00.0%UnchangedHistory
PMVPPMV Pharmaceuticals, Inc.COM989,232$6.07M13.7%00.0%UnchangedHistory
LENZLENZ Therapeutics, Inc.COM406,308$1.01M2.3%00.0%UnchangedHistory
RNACCartesian Therapeutics, Inc.COM862,543$914.3K2.1%00.0%UnchangedHistory
VORVor Biopharma Inc.COM374,714$794.4K1.8%00.0%UnchangedHistory
EFTReFFECTOR Therapeutics, Inc.COM1,025,697$615.3K1.4%00.0%UnchangedHistory
DTILPrecision Biosciences IncCOM1,123,913$383.6K0.9%00.0%UnchangedHistory
SPROSpero Therapeutics, Inc.COM249,070$301.4K0.7%00.0%UnchangedHistory
IMAImageneBio, Inc.COM26,833$116.2K0.3%+26,833NewHistory
QTTBQ32 Bio Inc.COM64,000$74.9K0.2%00.0%UnchangedHistory

Sold out since Q2 2023 (1)

Positions held at the end of Q2 2023 that are gone from this filing.

Positions of OUP Management Co., LLC sold out since Q2 2023
SecurityClassShares in Q2 2023Value in Q2 2023% of portfolio in Q2 2023History
DICEDICE Therapeutics, Inc.COM268,346$12.5M21.3%History